Thermo Fisher Scientific | TMO - Net Income


Thermo Fisher Scientific reported $1.74B in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD 37M 47M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
General Electric Aerospace USD 2.37B 466M Jun/2026
Henry Schein USD 94M 13M Jun/2026
Illumina USD 207M 73M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Olympus JPY 19.1B 5.71B Jun/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quest Diagnostics USD 320M 69M Jun/2026
Repligen USD 5.01M 3.32M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Veracyte USD 25.49M 3.22M Jun/2026
Waters USD -136M 64M Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026